Hull Hans
Insider CIK 1614876 · AAVL SVP, Legal and Corp. Dev. · PLRX Chief Business Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2025-01-23 | 2025-01-27 | 80,300 | — | $0 | 80,300 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2025-01-23 | 2025-01-27 | 40,150 | — | $0 | 251,708 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2025-01-17 | 2025-01-22 | 15,936 | $11.20 | $178.5K | 211,558 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2024-07-10 | 2024-07-12 | 9,900 | $11.56 | $114.4K | 227,494 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2024-07-09 | 2024-07-11 | 19,337 | — | $0 | 237,394 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2024-01-23 | 2024-01-24 | 63,000 | — | $0 | 63,000 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2024-01-23 | 2024-01-24 | 31,500 | — | $0 | 216,569 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2024-01-17 | 2024-01-19 | 9,786 | $17.23 | $168.6K | 185,069 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2023-08-04 | 2023-08-07 | 8,791 | — | $0 | 31,367 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2023-08-04 | 2023-08-07 | 8,791 | $2.08 | $18.3K | 214,905 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-08-04 | 2023-08-07 | 20,050 | $20.01 | $401.2K | 194,855 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2023-08-03 | 2023-08-07 | 1,800 | — | $0 | 40,158 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-08-03 | 2023-08-07 | 1,800 | $20.00 | $36.0K | 206,114 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-08-03 | 2023-08-07 | 13,069 | $20.00 | $261.4K | 206,114 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2023-08-03 | 2023-08-07 | 1,800 | $2.08 | $3.7K | 207,914 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-07-17 | 2023-07-19 | 17,937 | $18.01 | $323.0K | 219,183 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2023-07-14 | 2023-07-18 | 35,156 | — | $0 | 237,120 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-03-30 | 2023-04-03 | 9,036 | $26.52 | $239.6K | 201,964 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2023-03-29 | 2023-03-31 | 17,578 | — | $0 | 211,000 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2023-01-25 | 2023-01-27 | 76,200 | — | $0 | 76,200 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2023-01-25 | 2023-01-27 | 54,000 | — | $0 | 192,191 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2022-12-20 | 2022-12-21 | 8,748 | $19.10 | $167.1K | 138,191 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2022-12-19 | 2022-12-21 | 17,578 | — | $0 | 146,939 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2022-01-26 | 2022-02-02 | 112,500 | — | $0 | 112,500 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2021-05-26 | 2021-05-28 | 4,500 | — | $0 | 12,979 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2021-05-26 | 2021-05-28 | 4,500 | $2.08 | $9.4K | 125,246 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2021-01-23 | 2021-01-26 | 62,250 | — | $0 | 62,250 | SEC↗ |
| PLRX | M Exercise deriv | 2020-12-30 | 2021-01-04 | 3,500 | — | $0 | 17,479 | SEC↗ |
| PLRX | M Exercise | 2020-12-30 | 2021-01-04 | 3,500 | $2.08 | $7.3K | 120,746 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | C Conversion deriv | 2020-06-05 | 2020-06-09 | 36,319 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | C Conversion deriv | 2020-06-05 | 2020-06-09 | 27,322 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | C Conversion | 2020-06-05 | 2020-06-09 | 5,079 | — | $0 | 117,246 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | C Conversion | 2020-06-05 | 2020-06-09 | 3,821 | — | $0 | 3,821 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2020-03-31 | 2020-06-09 | 70,352 | — | $0 | 70,352 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2020-02-28 | 2020-06-09 | 27,322 | $13.08 | $357.4K | 27,322 | SEC↗ |
| AAVL Avalanche Biotechnologies, | A Award | 2015-08-21 | 2015-08-25 | 117,590 | — | $0 | 137,210 | SEC↗ |
| AAVL Avalanche Biotechnologies, | M Exercise deriv | 2015-06-12 | 2015-06-16 | 8,300 | — | $0 | 12,200 | SEC↗ |
| AAVL Avalanche Biotechnologies, | M Exercise | 2015-06-12 | 2015-06-16 | 8,300 | $0.19 | $1.6K | 19,620 | SEC↗ |
| [AAVL] Avalanche Biotechnologies, | M Exercise deriv | 2015-06-04 | 2015-06-05 | 2,000 | — | $0 | 20,500 | SEC↗ |
| [AAVL] Avalanche Biotechnologies, | M Exercise | 2015-06-04 | 2015-06-05 | 2,000 | $0.19 | $380 | 13,320 | SEC↗ |
| [AAVL] Avalanche Biotechnologies, | S Sale | 2015-06-04 | 2015-06-05 | 2,000 | $37.64 | $75.3K | 11,320 | SEC↗ |
| AAVL Avalanche Biotechnologies, | M Exercise deriv | 2015-05-04 | 2015-05-06 | 5,000 | — | $0 | 22,500 | SEC↗ |
| AAVL Avalanche Biotechnologies, | M Exercise | 2015-05-04 | 2015-05-06 | 5,000 | $0.19 | $950 | 16,320 | SEC↗ |
| AAVL Avalanche Biotechnologies, | S Sale | 2015-05-04 | 2015-05-06 | 5,000 | $30.87 | $154.3K | 11,320 | SEC↗ |
| AAVL Avalanche Biotechnologies, | A Award deriv | 2015-04-21 | 2015-04-23 | 23,000 | — | $0 | 23,000 | SEC↗ |
| AAVL Avalanche Biotechnologies, | A Award | 2015-04-21 | 2015-04-23 | 8,000 | — | $0 | 11,320 | SEC↗ |
| AAVL Avalanche Biotechnologies, | M Exercise deriv | 2015-04-07 | 2015-04-08 | 27,500 | — | $0 | 27,500 | SEC↗ |
| AAVL Avalanche Biotechnologies, | S Sale | 2015-04-07 | 2015-04-08 | 26,613 | $38.59 | $1.03M | 4,207 | SEC↗ |
| AAVL Avalanche Biotechnologies, | M Exercise | 2015-04-07 | 2015-04-08 | 27,500 | $0.19 | $5.2K | 30,820 | SEC↗ |
| AAVL Avalanche Biotechnologies, | S Sale | 2015-04-07 | 2015-04-08 | 887 | $39.06 | $34.6K | 3,320 | SEC↗ |
| AAVL Avalanche Biotechnologies, | C Conversion deriv | 2014-08-05 | 2014-08-07 | 3,320 | — | $0 | 0 | SEC↗ |
| AAVL Avalanche Biotechnologies, | C Conversion | 2014-08-05 | 2014-08-07 | 3,320 | — | $0 | 3,320 | SEC↗ |
| AAVL Avalanche Biotechnologies, | A Award deriv | 2014-07-30 | 2014-08-01 | 75,000 | — | $0 | 75,000 | SEC↗ |